文献速递肝病消化道肿瘤与早癌

肝细胞癌中的肠道微生物组:机制、诊断与治疗

Gut microbiome in HCC - Mechanisms, diagnosis and therapy.
PubMed 文献 · J Hepatol · 2020-01-01

本文综述肠道微生物组在肝细胞癌(HCC)中的作用,HCC 是全球癌症死亡的第三大原因。文章讨论肠-肝轴通过菌群失调、肠漏和细菌代谢物促进 HCC 发生的机制,重点关注非酒精性脂肪性肝病(NAFLD)这一增长最快的病因,并总结微生物组作为诊断工具和免疫治疗靶点的进展。

要点

  • 肠-肝轴通过菌群失调、肠漏及细菌代谢物促进 HCC 发生发展
  • NAFLD 是 HCC 增长最快的病因,是微生物组研究的重点场景
  • 肠道微生物组有望成为 HCC 诊断工具及免疫治疗的新靶点

核心结论

  • 肠道微生物组通过肠-肝轴参与 HCC 的发生发展,并有望作为 HCC 诊断与治疗的新靶点。

研究设计与样本

  • 综述,基于小鼠模型与患者证据,总结肠道微生物组在 HCC 中的机制、诊断与治疗进展。

主要发现

  • 微生物组调控代谢、炎症与免疫等关键过程,并在致癌作用及抗癌免疫应答中发挥重要作用。
  • HCC 多发生于病毒性肝炎、NAFLD 及酒精相关脂肪性肝病所致的慢性肝病患者。
  • 肠-肝轴通过菌群失调、肠漏和细菌代谢物促进 HCC 发展,NAFLD 为增长最快的病因。
  • 微生物组作为诊断工具及治疗靶点的研究近期取得进展,尤其在免疫治疗背景下。

临床怎么用

  • 对 HCC 患者尤其是 NAFLD 相关 HCC,可关注肠道微生物组作为潜在诊断与免疫治疗干预方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The microbiome exerts essential functions in health and disease, modulating key processes in metabolism, inflammation and immunity. Recent evidence has revealed a key role of the microbiome in carcinogenesis as well as anti-cancer immune responses in mouse models and patients. Herein, we will review functions of the gut microbiome in hepatocellular carcinoma (HCC), the third leading cause of worldwide cancer mortality. The majority of HCC develops in patients with chronic liver disease, caused by viral hepatitis, non-alcoholic fatty liver disease (NAFLD) and alcohol-related fatty liver disease. In this review, we will discuss mechanisms by which the gut-liver axis promotes the development of HCC in mouse models and patients, including dysbiosis, the leaky gut and bacterial metabolites, with a particular focus on NAFLD as the fastest growing cause of HCC development. Moreover, we will review recent progress in harnessing the gut microbiome as a potential diagnostic tool and novel therapeutic target in patients with HCC, in particular in the setting of immunotherapy.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Schwabe RF, Greten TF. Gut microbiome in HCC - Mechanisms, diagnosis and therapy. J Hepatol. 2020. PMID: 31954488. doi:10.1016/j.jhep.2019.08.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。